These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 12732733)

  • 1. Binding and recognition in the assembly of an active BRCA1/BARD1 ubiquitin-ligase complex.
    Brzovic PS; Keeffe JR; Nishikawa H; Miyamoto K; Fox D; Fukuda M; Ohta T; Klevit R
    Proc Natl Acad Sci U S A; 2003 May; 100(10):5646-51. PubMed ID: 12732733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of BRCA1 E3 ubiquitin ligase activity through direct interaction with the BARD1 protein.
    Xia Y; Pao GM; Chen HW; Verma IM; Hunter T
    J Biol Chem; 2003 Feb; 278(7):5255-63. PubMed ID: 12431996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The BRCA1/BARD1 heterodimer, a tumor suppressor complex with ubiquitin E3 ligase activity.
    Baer R; Ludwig T
    Curr Opin Genet Dev; 2002 Feb; 12(1):86-91. PubMed ID: 11790560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation.
    Hashizume R; Fukuda M; Maeda I; Nishikawa H; Oyake D; Yabuki Y; Ogata H; Ohta T
    J Biol Chem; 2001 May; 276(18):14537-40. PubMed ID: 11278247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of a BRCA1-BARD1 heterodimeric RING-RING complex.
    Brzovic PS; Rajagopal P; Hoyt DW; King MC; Klevit RE
    Nat Struct Biol; 2001 Oct; 8(10):833-7. PubMed ID: 11573085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear-cytoplasmic shuttling of BARD1 contributes to its proapoptotic activity and is regulated by dimerization with BRCA1.
    Rodriguez JA; Schüchner S; Au WW; Fabbro M; Henderson BR
    Oncogene; 2004 Mar; 23(10):1809-20. PubMed ID: 14647430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the E3 ligase function of the BRCA1/BARD1 complex by polyubiquitin chains.
    Mallery DL; Vandenberg CJ; Hiom K
    EMBO J; 2002 Dec; 21(24):6755-62. PubMed ID: 12485996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mass spectrometric and mutational analyses reveal Lys-6-linked polyubiquitin chains catalyzed by BRCA1-BARD1 ubiquitin ligase.
    Nishikawa H; Ooka S; Sato K; Arima K; Okamoto J; Klevit RE; Fukuda M; Ohta T
    J Biol Chem; 2004 Feb; 279(6):3916-24. PubMed ID: 14638690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoubiquitination of the BRCA1*BARD1 RING ubiquitin ligase.
    Chen A; Kleiman FE; Manley JL; Ouchi T; Pan ZQ
    J Biol Chem; 2002 Jun; 277(24):22085-92. PubMed ID: 11927591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The BRCA1/BARD1 heterodimer assembles polyubiquitin chains through an unconventional linkage involving lysine residue K6 of ubiquitin.
    Wu-Baer F; Lagrazon K; Yuan W; Baer R
    J Biol Chem; 2003 Sep; 278(37):34743-6. PubMed ID: 12890688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A UbcH5/ubiquitin noncovalent complex is required for processive BRCA1-directed ubiquitination.
    Brzovic PS; Lissounov A; Christensen DE; Hoyt DW; Klevit RE
    Mol Cell; 2006 Mar; 21(6):873-80. PubMed ID: 16543155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The BRCA1/BARD1 ubiquitin ligase and its substrates.
    Witus SR; Stewart MD; Klevit RE
    Biochem J; 2021 Sep; 478(18):3467-3483. PubMed ID: 34591954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping the functional domains of BRCA1. Interaction of the ring finger domains of BRCA1 and BARD1.
    Meza JE; Brzovic PS; King MC; Klevit RE
    J Biol Chem; 1999 Feb; 274(9):5659-65. PubMed ID: 10026184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer-predisposing mutations within the RING domain of BRCA1: loss of ubiquitin protein ligase activity and protection from radiation hypersensitivity.
    Ruffner H; Joazeiro CA; Hemmati D; Hunter T; Verma IM
    Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5134-9. PubMed ID: 11320250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a RING protein that can interact in vivo with the BRCA1 gene product.
    Wu LC; Wang ZW; Tsan JT; Spillman MA; Phung A; Xu XL; Yang MC; Hwang LY; Bowcock AM; Baer R
    Nat Genet; 1996 Dec; 14(4):430-40. PubMed ID: 8944023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of biochemical reactions through supramolecular RING domain self-assembly.
    Kentsis A; Gordon RE; Borden KL
    Proc Natl Acad Sci U S A; 2002 Nov; 99(24):15404-9. PubMed ID: 12438698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negative feedback loop of BRCA1-BARD1 ubiquitin ligase on estrogen receptor alpha stability and activity antagonized by cancer-associated isoform of BARD1.
    Dizin E; Irminger-Finger I
    Int J Biochem Cell Biol; 2010 May; 42(5):693-700. PubMed ID: 20060929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tuning BRCA1 and BARD1 activity to investigate RING ubiquitin ligase mechanisms.
    Stewart MD; Duncan ED; Coronado E; DaRosa PA; Pruneda JN; Brzovic PS; Klevit RE
    Protein Sci; 2017 Mar; 26(3):475-483. PubMed ID: 27977889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen receptor alpha is a putative substrate for the BRCA1 ubiquitin ligase.
    Eakin CM; Maccoss MJ; Finney GL; Klevit RE
    Proc Natl Acad Sci U S A; 2007 Apr; 104(14):5794-9. PubMed ID: 17392432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conservation of function and primary structure in the BRCA1-associated RING domain (BARD1) protein.
    Ayi TC; Tsan JT; Hwang LY; Bowcock AM; Baer R
    Oncogene; 1998 Oct; 17(16):2143-8. PubMed ID: 9798686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.